ilyes Benlala

Dr. ilyes Benlala

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 September 2018 in Journal of Magnetic Resonance Imaging
Verified
Journal Article
Closed access
PDF file
GDGaël Dournes
Gaël Dournes
JYJoseph Yazbek
Joseph Yazbek
WBWadie Benhassen
Wadie Benhassen
IBilyes Benlala
ilyes Benlala
EBElodie Blanchard
Elodie Blanchard
FLFrançois Laurent
François Laurent

15 July 2021 in European Respiratory Journal
Verified
Journal Article
Closed access
PDF file
GDGaël Dournes
Gaël Dournes
CHChase S. Hall
Chase S. Hall
MWMatthew M. Willmering
Matthew M. Willmering
ABAlan S. Brody
Alan S. Brody
JMJulie Macey
Julie Macey
JWJason C. Woods
Jason C. Woods
Background: Chest computed tomography (CT) remains the imaging standard for demonstrating cystic fibrosis (CF) airway structural diseasein vivo. However, visual scoring systems as an outcome measure are time consuming, require training and lack high reproducibility. Our objective was to validate a fully automated artificial intelligence (AI)-driven scoring system of CF lung disease severity.Methods: Data were retrospectively collected in three CF reference centres, between 2008 and 2020, in 184 patients aged 4–54 years. An algorithm using three 2D convolutional neural networks was trained with 78 patients’ CT scans (23 530 CT slices) for the semantic labelling of bronchiectasis, peribronchial thickening, bronchial mucus, bronchiolar mucus and collapse/consolidation. 36 patients’ CT scans (11 435 CT slices) were used for testingversusground-truth labels. The method's clinical validity was assessed in an independent group of 70 patients with or without lumacaftor/ivacaftor treatment (n=10 and n=60, respectively) with repeat examinations. Similarity and reproducibility were assessed using the Dice coefficient, correlations using the Spearman test, and paired comparisons using the Wilcoxon rank test.Results: The overall pixelwise similarity of AI-drivenversusground-truth labels was good (Dice 0.71). All AI-driven volumetric quantifications had moderate to very good correlations to a visual imaging scoring (p<0.001) and fair to good correlations to forced expiratory volume in 1 s % predicted at pulmonary function tests (p0.99).Conclusion: AI allows fully automated volumetric quantification of CF-related modifications over an entire lung. The novel scoring system could provide a robust disease outcome in the era of effective CF transmembrane conductance regulator modulator therapy.

1 July 2023 in Radiology
Verified
Journal Article
Closed access
ALArthur Longuefosse
Arthur Longuefosse
JRJulien Raoult
Julien Raoult
IBilyes Benlala
ilyes Benlala
BSBaudouin Denis de Senneville
Baudouin Denis de Senneville
TBThomas Benkert
Thomas Benkert
GDGaël Dournes
Gaël Dournes

1 January 2020 in Radiology
Verified
Journal Article
Closed access
IBilyes Benlala
ilyes Benlala
FHFrançois Hocke
François Hocke
JMJulie Macey
Julie Macey
SBStéphanie Bui
Stéphanie Bui
PBPatrick Berger
Patrick Berger
GDGaël Dournes
Gaël Dournes
Automated and reproducible quantification of high-signal-intensity volume of the lungs by using MRI was feasible in participants with cystic fibrosis to monitor inflammation and response to treatment. Background In patients with cystic fibrosis (CF), pulmonary structures with high MRI T2 signal intensity relate to inflammatory changes in the lung and bronchi. These areas of pathologic abnormalit...

1 July 2019 in Radiology
Verified
Journal Article
Closed access
IBilyes Benlala
ilyes Benlala
PBPatrick Berger
Patrick Berger
PGPierre-Olivier Girodet
Pierre-Olivier Girodet
CDClaire Dromer
Claire Dromer
JMJulie Macey
Julie Macey
GDGaël Dournes
Gaël Dournes
In this pilot study, we validated an automated method to reliably quantify the severity of emphysema from three-dimensional ultrashort echo time lung MRI. BackgroundThe validity of three-dimensional (3D) ultrashort echo time (UTE) MRI for the assessment of emphysema in patients with chronic obstructive pulmonary disease (COPD) at high spatial resolut...

20 October 2023 in Journal of Magnetic Resonance Imaging
Verified
Journal Article
Open access
MDMathieu David
Mathieu David
IBilyes Benlala
ilyes Benlala
SBStephanie Bui
Stephanie Bui
TBThomas Benkert
Thomas Benkert
PBPatrick Berger
Patrick Berger
GDGaël Dournes
Gaël Dournes
Background: Lung magnetic resonance imaging (MRI) with ultrashort echo‐times (UTE‐MRI) allows high‐resolution and radiation‐free imaging of the lung structure in cystic fibrosis (CF). In addition, the combination of elexacaftor/tezacaftor/ivacaftor (ETI) has improved CF clinical outcomes such as need for hospitalization. However, the effect on structural disease still needs longitudinal evaluation at high resolution.Purpose: To analyze the effects of ETI on lung structural alterations using UTE‐MRI, with a focus on bronchiectasis reversibility.Study Type: Retrospective.Population: Fifty CF patients (mean age 24.3 ± 9.2; 23 males).Field Strength/Sequence: 1.5 T, UTE‐MRI.Assessment: All subjects completed both UTE‐MRI and pulmonary function tests (PFTs) during two annual visits (M0 and M12), and 30 of them completed a CT scan. They initiated ETI treatment after M0 within a maximum of 3 months from the annual examinations. Three observers scored a clinical MRI Bhalla score on UTE‐MRI. Bronchiectasis reversibility was defined as a reduction in both outer and inner bronchial dimensions. Correlations were searched between the Bhalla score and PFT such as the forced expiratory volume in 1 second percentage predicted (FEV1%p).Statistical Tests: Comparison was assessed using the paired t‐test, correlation using the Spearman correlation test with a significance level of 0.05. Concordance and reproducibility were assessed using intraclass correlation coefficient (ICC).Results: There was a significant improvement in MRI Bhalla score after ETI treatment. UTE‐MRI demonstrated bronchiectasis reversibility in a subgroup of 18 out of 50 CF patients (36%). These patients with bronchiectasis reversibility were significantly younger, with lower severity of wall thickening but no difference in mucus plugging extent (P = 0.39) was found. The reproducibility of UTE‐MRI evaluations was excellent (ICC ≥ 0.95), was concordant with CT scan (N = 30; ICC ≥ 0.90) and significantly correlated to FEV1% at PFT at M0 (N = 50; r = 0.71) and M12 (N = 50; r = 0.72).Data Conclusion: UTE‐MRI is a reproducible tool for the longitudinal follow‐up of CF patients, allowing to quantify the response to ETI and demonstrating the reversibility of some structural alterations such as bronchiectasis in a substantial fraction of this study population.Level of Evidence: 4Technical Efficacy: Stage 2